S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Disney Stock Catches 3 Upgrades In a Single Week
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Disney Stock Catches 3 Upgrades In a Single Week
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Disney Stock Catches 3 Upgrades In a Single Week
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Disney Stock Catches 3 Upgrades In a Single Week
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
TSE:TH

Theratechnologies (TH) Stock Price, News & Analysis

C$2.23
+0.25 (+12.63%)
(As of 03/28/2024 ET)
Today's Range
C$2.00
C$2.24
50-Day Range
C$1.64
C$2.65
52-Week Range
C$1.22
C$5.84
Volume
55,925 shs
Average Volume
43,763 shs
Market Capitalization
C$102.54 million
P/E Ratio
N/A
Dividend Yield
3.76%
Price Target
C$5.50

Theratechnologies MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
146.6% Upside
C$5.50 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.59 out of 5 stars

TH stock logo

About Theratechnologies Stock (TSE:TH)

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a recombinant humanized monoclonal antibody, which is an injection for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; and TH1902, which is in Phase 1 clinical trials for the treatment of various solid tumors, including HR+ breast cancer, triple negative breast cancer, ovarian cancer, endometrial cancer, melanoma, thyroid cancer, small cell lung cancer, and prostate cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

TH Stock Price History

TH Stock News Headlines

Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Here's what Wall Street expects from Theratechnologies's earnings report
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
7THTX : Theratechnologies Earnings Preview
3 Biotech Stock Buys to Boost and Supercharge Portfolios
Closing Bell: Theratechnologies flat on Monday (TH)
See More Headlines
Receive TH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/21/2024
Today
3/29/2024
Next Earnings (Estimated)
4/10/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
103
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$5.50
High Stock Price Target
C$5.50
Low Stock Price Target
C$5.50
Potential Upside/Downside
+146.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
C$-23,960,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$81.76 million
Cash Flow
C$0.59 per share
Book Value
C($0.45) per share

Miscellaneous

Free Float
N/A
Market Cap
C$102.54 million
Optionable
Not Optionable
Beta
1.73
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Paul Lévesque (Age 59)
    President, CEO & Director
    Comp: $1.6M
  • Mr. Philippe Dubuc M.B.A. (Age 57)
    MBA, Senior VP & CFO
    Comp: $585.32k
  • Mr. Jocelyn Lafond L.L.M. (Age 56)
    LL.B., General Counsel & Corporate Secretary
    Comp: $428.24k
  • Dr. Christian Marsolais Ph.D. (Age 61)
    Senior VP & Chief Medical Officer
    Comp: $588.42k
  • Mr. John Leasure (Age 59)
    Global Commercial Officer
    Comp: $569.88k
  • Hon. Andre Dupras M.Sc. (Age 60)
    Vice President of Human Resources

TH Stock Analysis - Frequently Asked Questions

Should I buy or sell Theratechnologies stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" TH shares.
View TH analyst ratings
or view top-rated stocks.

What is Theratechnologies' stock price target for 2024?

2 Wall Street research analysts have issued 12-month price objectives for Theratechnologies' shares. Their TH share price targets range from C$5.50 to C$5.50. On average, they anticipate the company's stock price to reach C$5.50 in the next year. This suggests a possible upside of 146.6% from the stock's current price.
View analysts price targets for TH
or view top-rated stocks among Wall Street analysts.

How have TH shares performed in 2024?

Theratechnologies' stock was trading at C$2.14 at the beginning of 2024. Since then, TH shares have increased by 4.2% and is now trading at C$2.23.
View the best growth stocks for 2024 here
.

When is Theratechnologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 10th 2024.
View our TH earnings forecast
.

How were Theratechnologies' earnings last quarter?

Theratechnologies Inc. (TSE:TH) announced its quarterly earnings results on Wednesday, February, 21st. The company reported ($0.11) earnings per share (EPS) for the quarter. The business earned $31.93 million during the quarter. Theratechnologies had a negative net margin of 29.30% and a negative trailing twelve-month return on equity of 1,116.86%.

What other stocks do shareholders of Theratechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Theratechnologies investors own include Stars Group (TSGI), BCE (BCE), ProMetic Life Sciences (PLI), Teranga Gold (TGZ), Nemaska Lithium (NMX), Shopify (SHOP), United Therapeutics (UTHR) and Avigilon (AVO).

How do I buy shares of Theratechnologies?

Shares of TH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:TH) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners